Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist with focus on gastrointestinal malignancies at the Massachusetts General Hospital (MGH) Cancer Center. Dr. Ting’s laboratory utilizes RNA-sequencing and RNA in situ hybridization technologies for pancreatic cancer theranostics. He is co-Editor-in-Chief of the journal Cancer Convergence.